![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1383439
¿£µåÆ÷ÀÎÆ® µðÅØÅÍ ½ÃÀå ¿¹Ãø(-2030³â) : À¯Çüº°, ¿ëµµº°, Áö¿ªº° ¼¼°è ºÐ¼®End Point Detector Market Forecasts to 2030 - Global Analysis By Type, By Application and By Geography |
Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È CAGR 12.5%·Î ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù.
¿£µåÆ÷ÀÎÆ® µðÅØÅÍ´Â Å©·Î¸¶Åä±×·¡ÇÇ ¹× ÀûÁ¤ ½Ã½ºÅÛ°ú °°Àº ºÐ¼® Àåºñ ¹× °úÇÐ ±â±â¿¡ »ç¿ëµÇ´Â Àåºñ ¹× ¼ÒÇÁÆ®¿þ¾î ±â´ÉÀ¸·Î, ¹ÝÀÀ ¶Ç´Â ºÐ¼®ÀÌ Á¾Á¡¿¡ µµ´ÞÇÑ Á¤È®ÇÑ ½ÃÁ¡À» ½Äº°ÇÏ´Â ÀåÄ¡ ¹× ¼ÒÇÁÆ®¿þ¾î ±â´ÉÀÔ´Ï´Ù. Á¤È®ÇÑ ÃøÁ¤°ú °øÁ¤ÀÇ Á¤¹ÐÇÑ Á¦¾î¸¦ À§ÇØ ÇʼöÀûÀÌ¸ç ¿øÇÏ´Â °á°ú¸¦ ¾òÀ» ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù.
¹Ì±¹ÈÇÐ »ê¾÷Çùȸ(American Chemistry Council, Inc.)¿¡ µû¸£¸é, ÈÇлç¾÷Àº ¿¬°£ ¾à 5,170¾ï ´Þ·¯¸¦ âÃâÇÏ¸ç ¹Ì±¹ GDPÀÇ ¾à 25%¸¦ Â÷ÁöÇÕ´Ï´Ù.
Á¦¾à, ȯ°æ ¸ð´ÏÅ͸µ, ÈÇÐ ºÐ¼® µî ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡¼ ½Å¼ÓÇÑ ÀÇ»ç °áÁ¤°ú ǰÁú °ü¸®¸¦ À§ÇØ Áï°¢ÀûÀ̰í Áö¼ÓÀûÀÎ µ¥ÀÌÅͰ¡ ÇÊ¿äÇÕ´Ï´Ù. ½Ç½Ã°£ Á¾Á¡ °¨Áö ½Ã½ºÅÛÀº º¯ÈÇÏ´Â »óȲ¿¡ ½Å¼ÓÇÏ°Ô ´ëÀÀÇϰí Á¦Ç° ǰÁú, °øÁ¤ È¿À²¼º ¹× ±ÔÁ¦ Ç¥ÁØ Áؼö¸¦ º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä´Â ÇÁ·Î¼¼½º¸¦ ÃÖÀûÈÇϰí ÀÎÀû ¿À·ù¸¦ ÁÙÀ̸ç Àü¹ÝÀûÀÎ »ý»ê¼ºÀ» Çâ»ó½ÃÄÑ¾ß ÇÒ Çʿ伺¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ±× °á°ú, ½Ç½Ã°£ ±â´ÉÀ» Á¦°øÇÏ´Â ¿£µåÆ÷ÀÎÆ® °¨Áö±â°¡ Áõ°¡ÇÏ¸é¼ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ °í±Þ ŽÁö ½Ã½ºÅÛ¿¡´Â ¸¹Àº Ãʱâ ÅõÀÚ°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ´Â Áß¼Ò±â¾÷, ¿¬±¸¼Ò, ¿¹»êÀÌ ÇÑÁ¤µÈ Á¶Á÷¿¡°Ô´Â ÁøÀÔ À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¸·´ëÇÑ ºñ¿ë¿¡´Â ¿£µåÆ÷ÀÎÆ® ŽÁö Àåºñ ±¸¸Å»Ó¸¸ ¾Æ´Ï¶ó ¼³Ä¡, ±³À° ¹× Áö¼ÓÀûÀÎ À¯Áöº¸¼ö ºñ¿ëµµ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ °æÁ¦Àû ºÎ´ãÀº °í±Þ ¿£µåÆ÷ÀÎÆ® ŽÁö±âÀÇ Ã¤ÅÃÀ» ¹æÇØÇϰí, ÀڱݷÂÀÌ ÀÖ´Â ±â°ü°ú ±â¾÷ÀÇ Á¦ÇÑµÈ ¹üÀ§¿¡¼¸¸ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö, Á¦¾à, ȯ°æ °úÇÐ µîÀÇ ºÐ¾ß¿¡¼ ¿¬±¸ Ȱµ¿ÀÌ È®´ëµÊ¿¡ µû¶ó Á¤¹ÐÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ¿£µåÆ÷ÀÎÆ® °ËÃ⠽ýºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¬±¸ÀÚµéÀº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸®°í, Á¦Ç° ǰÁúÀ» º¸ÀåÇϸç, ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·Çϱâ À§ÇØ Á¤È®ÇÑ µ¥ÀÌÅ͸¦ ÇÊ¿ä·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ Á¦Á¶¾÷üµéÀÌ Æ¯Á¤ ¿¬±¸ ¿ä±¸¿¡ ¸Â´Â °íµµÀÇ ÀûÀÀ¼º, ÀûÀÀ¼º, È¿À²¼ºÀ» °®Ãá ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Çõ½Å°ú Ä¿½ºÅ͸¶ÀÌ¡¿¡ ÁßÁ¡À» µÎ¸é ±â¾÷Àº ÀÌ ±âȸ¸¦ Ȱ¿ëÇØ ´Ù¾çÇÑ ¿¬±¸ ¿ëµµ¿¡ ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù.
°æ±â ħü±â¿¡´Â ±â¾÷µéÀÌ ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ¿Í °°Àº ºÐ¼® Àåºñ¿¡ ´ëÇÑ ÅõÀÚ¸¦ Æ÷ÇÔÇÏ¿© ¼³ºñ ÅõÀÚ¸¦ ÁÙÀÌ´Â °æ¿ì°¡ ¸¹À¸¸ç, ÀÌ·Î ÀÎÇØ ½ÃÀå ¼ö¿ä°¡ °¨¼ÒÇÒ ¼ö ÀÖ½À´Ï´Ù. ±ÝÀ¶ ½ÃÀåÀÇ ºÒÈ®½Ç¼º ¶ÇÇÑ ÇÁ·ÎÁ§Æ® ¿¬±â ¹× Áß´ÜÀ¸·Î À̾îÁ® Á¶Á÷ÀÇ ±¸¸Å °áÁ¤¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¾î·Á¿î °æÁ¦ »óȲ¿¡¼´Â R&D ¿¹»êÀÌ ¾ïÁ¦µÇ¾î ±â¼ú Çõ½Å°ú ÷´Ü ¿£µåÆ÷ÀÎÆ® ŽÁö ±â¼ú °³¹ßÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
COVID-19 ÆÒµ¥¹ÍÀº ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâ°ú ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¸ðµÎ ¹ÌÃÆ½À´Ï´Ù. °ø±Þ¸Á°ú Á¦Á¶ÀÇ È¥¶õ, ½ÇÇè½Ç Á¢±Ù Á¦ÇÑ µîÀ¸·Î ÀÎÇØ ÀϽÃÀûÀ¸·Î ½ÃÀå ¼ºÀåÀÌ µÐȵÆÁö¸¸, ÆÒµ¥¹Í ±â°£ µ¿¾È ÇコÄɾî¿Í Áø´Ü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ COVID-19 °Ë»ç¿Í °°Àº ¿ëµµ·Î ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù. ½Å¼ÓÇϰí Á¤È®ÇÑ ¿£µåÆ÷ÀÎÆ® ÆÇÁ¤ÀÇ Çʿ伺ÀÌ Áø´Ü ÇÁ·Î¼¼½º¿¡¼ °¡Àå Áß¿äÇÑ ¿ä¼Ò·Î ¶°¿À¸£¸é¼ ½ÃÀå¿¡ ºñÁö´Ï½º ±âȸ¸¦ âÃâÇß½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ÆÒµ¥¹ÍÀº ÀÇ·á ¹× Á¦¾à ºÐ¾ß¿¡¼ ¿£µåÆ÷ÀÎÆ® °ËÃâÀÇ Á߿伺À» °Á¶ÇßÀ¸¸ç, »óȲÀÌ ÁøÇàµÊ¿¡ µû¶ó ½ÃÀåÀº º¯ÈÇÏ´Â »ê¾÷ ¿ªÇп¡ °è¼Ó ÀûÀÀÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Àü±âÈÇÐ ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ ºÎ¹®Àº È¿À²¼º°ú ȯ°æÀû ÀÌÁ¡À¸·Î ÀÎÇØ À¯¸®ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ °¨Áö±â´Â Àü·ù ¹× ÀüÀ§¿Í °°Àº Àü±â ½ÅÈ£ÀÇ º¯È¸¦ ¸ð´ÏÅ͸µÇÏ¿© ÈÇÐ ¹ÝÀÀÀÇ Á¤È®ÇÑ Á¾Á¡À» ½Äº°ÇÕ´Ï´Ù. ÀϹÝÀûÀ¸·Î »êÈ È¯¿ø ÀûÁ¤ ¹× ±âŸ Àü±â ÈÇÐ °øÁ¤¿¡¼ ¹ÝÀÀ¹°ÀÌ ¿ÏÀüÈ÷ ¹ÝÀÀÇÑ Á¤È®ÇÑ ½ÃÁ¡À» È®ÀÎÇϱâ À§ÇØ »ç¿ëµË´Ï´Ù. Àü±âÈÇÐ ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ´Â ¸Å¿ì Á¤È®Çϰí Á¤¹ÐÇÑ °á°ú¸¦ Á¦°øÇϱ⠶§¹®¿¡ ÀǾàǰ, ȯ°æ ¸ð´ÏÅ͸µ, ǰÁú °ü¸®¿Í °°ÀÌ ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¾Á¡ °áÁ¤ÀÇ Çʿ伺ÀÌ Á¦Ç° ǰÁú°ú »ê¾÷ Ç¥ÁØ Áؼö¸¦ º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ »ê¾÷¿¡¼ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ¾ú½À´Ï´Ù.
Á¦¾à »ê¾÷ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ´Â ÈÇÐ ¹ÝÀÀÀÇ Á¾Á¡À» °áÁ¤ÇÏ°í ¾à¹°ÀÇ Á¤È®ÇÑ Åõ¿© ¹× ó¹æÀ» º¸ÀåÇϱâ À§ÇØ Á¦¾à ¿¬±¸ ¹× ǰÁú °ü¸®¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ´Â ÀǾàǰ Ȱ¼º ¼ººÐÀÇ ÇÕ¼º ¸ð´ÏÅ͸µºÎÅÍ Á¦Á¶ ½Ã ǰÁú º¸Áõ, ±ÔÁ¦ Áؼö Áö¿ø, ÀϰüµÈ Á¦Ç° ǰÁú À¯Áö¿¡ À̸£±â±îÁö ÀǾàǰ °³¹ß¿¡¼ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¦¾à °øÁ¤¿¡¼ ¿£µåÆ÷ÀÎÆ® °ËÃâÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀº ȯÀÚ ¾ÈÀü°ú ¾ö°ÝÇÑ »ê¾÷ Ç¥ÁØ Áؼö¸¦ À§ÇØ ÇʼöÀûÀ̸ç, ÀÌ ºÐ¾ß¿¡¼ ÇʼöÀûÀÎ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì ½ÃÀåÀÌ ½ÃÀå Á¡À¯À²ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÎ¹®ÀÌ Àß ¹ß´ÞµÇ¾î ÀÖ¾î ǰÁú °ü¸® ¹× ¿¬±¸¸¦ À§ÇØ Á¤¹ÐÇÑ ¿£µåÆ÷ÀÎÆ® °ËÃ⠽ýºÅÛÀ» ÇÊ¿ä·Î Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ö°ÝÇÑ È¯°æ ±ÔÁ¦¿Í ½Äǰ ¹× À½·á »ê¾÷ÀÇ Á¦Ç° ǰÁú¿¡ ´ëÇÑ Á߿伺ÀÌ ºÐ¼® ¸ñÀûÀÇ ¿£µåÆ÷ÀÎÆ® µðÅØÅÍ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀ» ¼±µµÇÏ´Â ±â¾÷µéÀÇ Á¸Àç¿Í Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ³ë·Âµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì Áö¿ª¿¡¼´Â ÀÚµ¿È¿Í È¿À²¼ºÀÌ °Á¶µÇ°í ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº »ê¾÷ ±â¹ÝÀÌ È®´ëµÇ°í R&D Ȱµ¿¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼ ½ÃÀåÀÌ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡ÀÇ Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ºÎ¹®Àº °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» º¸À̰í ÀÖÀ¸¸ç, ÀÌ´Â ÀǾàǰ °³¹ß ¹× ǰÁú °ü¸®¿¡¼ Á¤¹ÐÇÑ ¿£µåÆ÷ÀÎÆ® °ËÃ⠽ýºÅÛ¿¡ ´ëÇÑ Å« ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ª¿¡¼ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Â ÈÇÐ ¹× ¼®À¯ÈÇÐ »ê¾÷Àº °øÁ¤ ÃÖÀûȸ¦ À§ÇØ ½Å·ÚÇÒ ¼ö ÀÖ´Â ¿£µåÆ÷ÀÎÆ® µðÅØÅ͸¦ ÇÊ¿ä·Î ÇÕ´Ï´Ù. ȯ°æ ¹®Á¦¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ±ÔÁ¦°¡ °ÈµÊ¿¡ µû¶ó Á¤È®ÇÑ ¿£µåÆ÷ÀÎÆ® ÆÇ´ÜÀÇ Çʿ伺ÀÌ ½ÃÀåÀ» ´õ¿í Ȱ¼ºÈ½Ã۰í ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global End Point Detector Market is growing at a CAGR of 12.5% during the forecast period. An endpoint detector is a device or software feature used in analytical and scientific instruments, such as chromatography or titration systems, to identify the exact point at which a reaction or analysis has reached its endpoint. It is essential for accurate measurements and precise control of processes, ensuring that the desired outcome is achieved.
According to the American Chemistry Council, Inc., around US$ 517 billion is generated annually by the business of chemistry, and it contributes around 25% to the U.S GDP.
Industries across various sectors, including pharmaceuticals, environmental monitoring, and chemical analysis, require immediate and continuous data to make prompt decisions and maintain quality control. Real-time endpoint detection systems enable swift response to changing conditions, ensuring product quality, process efficiency, and compliance with regulatory standards. This demand is fueled by the need to optimize processes, reduce human error, and improve overall productivity. As a result, endpoint detectors that offer real-time capabilities are increasing, further propelling market growth.
These sophisticated detection systems often require a significant initial investment, which can be a barrier to entry for smaller businesses, research laboratories, or organizations with limited budgets. The substantial cost includes not only the purchase of the endpoint detection equipment but also installation, training, and ongoing maintenance expenses. This financial burden can hinder the adoption of advanced endpoint detectors, limiting their accessibility to a narrower range of well-funded institutions or enterprises.
As research endeavors expand in fields like biotechnology, pharmaceuticals, and environmental science, there is an increased demand for precise and reliable endpoint detection systems. Researchers require accurate data to make informed decisions, ensure product quality, and meet regulatory requirements. This trend opens doors for endpoint detector manufacturers to provide advanced, adaptable, and efficient solutions tailored to specific research needs. With an emphasis on innovation and customization, companies can tap into this opportunity to serve diverse research applications.
During economic downturns, companies often reduce capital expenditures, including investments in analytical instruments like endpoint detectors, which can result in a decline in market demand. Uncertainties in financial markets can also lead to postponed or canceled projects, impacting the purchasing decisions of organizations. Furthermore, in such challenging economic conditions, research and development budgets may be constrained, hindering innovation and the development of advanced endpoint detection technologies.
The COVID-19 pandemic had both positive and negative impacts on the endpoint detector market. While disruptions in supply chains and manufacturing, as well as restricted laboratory access, temporarily slowed down market growth, the increased focus on healthcare and diagnostics during the pandemic led to a surge in demand for endpoint detectors in applications like COVID-19 testing. The need for quick and accurate endpoint determination became paramount in diagnostic processes, creating opportunities for the market. Overall, the pandemic emphasized the importance of endpoint detection in healthcare and pharmaceuticals, and as the situation evolves, the market is expected to continue adapting to changing industry dynamics.
The electrochemical endpoint detectors segment is expected to have a lucrative growth due to its efficiency and environmental benefits. These detectors monitor changes in electrical signals, such as current or potential, to identify the precise endpoint of a chemical reaction. They are commonly used in redox titrations and other electrochemical processes to determine the exact point at which the reactants have completely reacted. Electrochemical endpoint detectors provide highly accurate and precise results, making them essential in industries like pharmaceuticals, environmental monitoring, and quality control, where the need for reliable endpoint determination is critical for ensuring product quality and compliance with industry standards.
The pharmaceutical industry segment is anticipated to witness the fastest CAGR growth during the forecast period. Endpoint detectors are extensively utilized in pharmaceutical research and quality control to determine the endpoint of chemical reactions, ensuring precise dosing and formulation of drugs. They play a pivotal role in drug development, from monitoring the synthesis of active pharmaceutical ingredients to quality assurance during production, supporting regulatory compliance, and maintaining consistent product quality. The accuracy and reliability of endpoint detection in pharmaceutical processes are essential for patient safety and compliance with stringent industry standards, making them indispensable tools in this sector.
During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. The region's well-established pharmaceutical and biotechnology sectors demand precise endpoint detection systems for quality control and research. Furthermore, stringent environmental regulations and a focus on product quality in the food and beverage industry drive the adoption of endpoint detectors for analytical purposes. The presence of leading market players and continuous R&D efforts also contribute to the market's growth. As North America places high importance on automation and efficiency.
The Asia Pacific region is witnessing rapid growth in the market driven by its expanding industrial base and increasing emphasis on research and development activities. The pharmaceutical and biotechnology sectors in countries like China and India are witnessing significant growth, creating a substantial demand for precise endpoint detection systems in drug development and quality control. Additionally, the region's booming chemical and petrochemical industries require reliable endpoint detectors for process optimization. With the growing awareness of environmental concerns and tightening regulations, the market is further fuelled by the need for accurate endpoint determination.
Some of the key players in End Point Detector market include: Agilent Technologies, Inc., Analytik Jena AG, Bio-Rad Laboratories, Inc., Bruker Corporation, Metrohm AG, Mettler-Toledo International Inc., PerkinElmer, Inc., Radiometer Analytical, Sartorius AG, Shimadzu Corporation and Thermo Fisher Scientific Inc.
In October 2023, Agilent Technologies Inc. announced the signing of a Memorandum of Understanding (MOU) with the Sarawak Infectious Disease Centre (SIDC) in East Malaysia. The agreement scope includes the provision of an Agilent 6475 triple quadrupole LC/MS system to boost the research advancement of neglected tropical diseases (NTDs) and other areas of disease over the next three years.
In September 2023, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications in basic and translational research, process development, and quality control.